Plans review pediatric antidepressant use in wake of FDA label change

Article

By withholding information about some antidepressant medications that cause an increase in suicidal tendencies among teenagers, the Food and Drug Administration (FDA) created heightened public concern about the value of antidepressants.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
A Conversation With IQVIA's Luke Greenwalt, MBA

A Conversation With IQVIA's Luke Greenwalt, MBA

Peter Wehrwein, Managing Editor
August 27th 2025
Article

Read More

David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'

David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'

August 27th 2025
Podcast

Listen

Upended: Can PBM Transparency Succeed?

Upended: Can PBM Transparency Succeed?

Peter Wehrwein, Managing Editor
August 27th 2025
Article

Read More

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Briana Contreras
August 27th 2025
Podcast

Listen

Image credit: © beebright stock.adobe.com

Change Healthcare Outage Prompts Switch in Pharmacy Claims Processing, Cranks Up Tensions Between Independent Pharmacies and PBMs

Peter Wehrwein, Managing Editor
August 27th 2025
Article

Read More

UnitedHealth Group Unplugs Change Healthcare Information Systems To Contain Cyberattack

UnitedHealth Group Unplugs Change Healthcare Information Systems To Contain Cyberattack

Peter Wehrwein, Managing Editor;Logan Lutton
August 27th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.